Serial changes in motor and somatosensory evoked potentials in putaminal haemorrhage.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Author(s): Misra UK;Misra UK; Kalita J
  • Source:
    Journal of neurology [J Neurol] 1996 Jan; Vol. 243 (1), pp. 73-8.
  • Publication Type:
    Journal Article
  • Language:
    English
  • Additional Information
    • Source:
      Publisher: Springer-Verlag Country of Publication: Germany NLM ID: 0423161 Publication Model: Print Cited Medium: Print ISSN: 0340-5354 (Print) Linking ISSN: 03405354 NLM ISO Abbreviation: J Neurol Subsets: MEDLINE
    • Publication Information:
      Original Publication: Berlin ; New York, Springer-Verlag
    • Subject Terms:
    • Abstract:
      Little is known about evoked potential changes in putaminal haemorrhage. In this study, somatosensory evoked potentials (SEPs) and motor evoked potentials (MEPs) have been serially evaluated and their role in the prognosis of putaminal haemorrhage is now reported. Nineteen patients with CT- or MRI-proven putaminal haemorrhage were examined after a mean duration of 13 days (range 2-30); there were 4 females and 9 males, ranging in age between 25 and 70 years. The haematomas were of medium size in 13 and large or small in 3 patients each. The changes in the clinical picture and the SEPs and MEPs were evaluated on admission, and after 30 and 90 days. Central motor conduction time (CMCT) could not be recorded in 13, but was prolonged in 2 and normal in 4 patients. Median SEPs revealed the absence of near field potentials in 11 and prolongation of N9-N20 conduction time in 1 patient. In the follow-up period MEP and SEP abnormalities only changed in 5 patients; MEPs changed in 4 and SEPs in 2. The period of normalisation of MEPs ranged between 1 and 6 months. CMCT correlated with motor and N9-N20 conduction time with sensory impairment. Eight patients had poor, 6 partial and 5 complete recovery. Power, sensation, CMCT, and size and location of haematoma made positive contributions to recovery.
    • References:
      Neuroradiology. 1990;32(3):200-6. (PMID: 2215904)
      Acta Neurol Scand. 1995 Apr;91(4):283-6. (PMID: 7625155)
      Lancet. 1992 Mar 14;339(8794):656-8. (PMID: 1347346)
      J Neurol Sci. 1987 Aug;80(1):91-110. (PMID: 3039071)
      Prog Brain Res. 1987;71:249-66. (PMID: 3588947)
      Md State Med J. 1965 Feb;14:61-5. (PMID: 14258950)
      Stroke. 1988 Feb;19(2):192-5. (PMID: 3344534)
      Electroencephalogr Clin Neurophysiol. 1980 Dec;50(5-6):404-25. (PMID: 6160983)
      Electroencephalogr Clin Neurophysiol. 1995 Oct;97(5):251-4. (PMID: 7489687)
      Ann Neurol. 1989 Jan;25(1):68-73. (PMID: 2913930)
      Brain. 1993 Dec;116 ( Pt 6):1371-85. (PMID: 8293276)
      J Neurol Neurosurg Psychiatry. 1994 May;57(5):572-7. (PMID: 8201326)
      Stroke. 1986 Jul-Aug;17(4):731-7. (PMID: 3738958)
      Electroencephalogr Clin Neurophysiol. 1995 Oct;97(5):255-8. (PMID: 7489688)
      Stroke. 1981 Sep-Oct;12 (5):648-52. (PMID: 7303052)
      J Med Chem. 1980 Jan;23(1):20-6. (PMID: 7359512)
    • Publication Date:
      Date Created: 19960101 Date Completed: 19970103 Latest Revision: 20190830
    • Publication Date:
      20221213
    • Accession Number:
      10.1007/BF00878535
    • Accession Number:
      8869391